These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors. Nguyen CT; Stephenson AJ Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611 [TBL] [Abstract][Full Text] [Related]
25. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy. Steyerberg EW; Keizer HJ; Sleijfer DT; Fossâ SD; Bajorin DF; Gerl A; de Wit R; Kirkels WJ; Koops HS; Habbema JD Radiology; 2000 May; 215(2):437-44. PubMed ID: 10796922 [TBL] [Abstract][Full Text] [Related]
26. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology? Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259 [TBL] [Abstract][Full Text] [Related]
27. The Role of Postchemotherapy Surgery in Germ Cell Tumors. Chéry L; Dash A Urol Clin North Am; 2015 Aug; 42(3):331-42. PubMed ID: 26216820 [TBL] [Abstract][Full Text] [Related]
28. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. Oldenburg J; Alfsen GC; Lien HH; Aass N; Waehre H; Fossa SD J Clin Oncol; 2003 Sep; 21(17):3310-7. PubMed ID: 12947067 [TBL] [Abstract][Full Text] [Related]
29. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection. Spiess PE; Tannir NM; Brown GA; Liu P; Tu SM; Evans JG; Pisters LL Urology; 2007 Dec; 70(6):1173-8. PubMed ID: 18158041 [TBL] [Abstract][Full Text] [Related]
30. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. Fox EP; Weathers TD; Williams SD; Loehrer PJ; Ulbright TM; Donohue JP; Einhorn LH J Clin Oncol; 1993 Jul; 11(7):1294-9. PubMed ID: 8391067 [TBL] [Abstract][Full Text] [Related]
31. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003]. Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676 [TBL] [Abstract][Full Text] [Related]
32. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings. Brown JA; Bihrle R; Foster RS Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916 [TBL] [Abstract][Full Text] [Related]
33. Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours. Horvath LG; McCaughan BC; Stockle M; Boyer MJ Intern Med J; 2002 Mar; 32(3):79-83. PubMed ID: 11885847 [TBL] [Abstract][Full Text] [Related]
34. Nonseminomatous germ cell tumor after chemotherapy with residual mass invading the spine. Berglund RK; Lyden SP; Tsai EC; Lieberman I; Klein EA Eur Urol; 2006 Aug; 50(2):372-4. PubMed ID: 16626860 [TBL] [Abstract][Full Text] [Related]
35. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. Toner GC; Panicek DM; Heelan RT; Geller NL; Lin SY; Bajorin D; Motzer RJ; Scher HI; Herr HW; Morse MJ J Clin Oncol; 1990 Oct; 8(10):1683-94. PubMed ID: 2170590 [TBL] [Abstract][Full Text] [Related]
36. Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer. Onozawa M; Kawai K; Yamamoto T; Hinotsu S; Tsukamoto S; Hattori K; Miyanaga N; Shimazui T; Akaza H Int J Urol; 2004 Jul; 11(7):535-41. PubMed ID: 15242364 [TBL] [Abstract][Full Text] [Related]